Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
30,266,227
-
Share change
-
-1,324,739
-
Total reported value
-
$39,328,312
-
Price per share
-
$1.30
-
Number of holders
-
64
-
Value change
-
-$2,264,348
-
Number of buys
-
16
-
Number of sells
-
40
Institutional Holders of Kronos Bio, Inc. - Common Stock (KRON) as of Q3 2023
As of 30 Sep 2023,
Kronos Bio, Inc. - Common Stock (KRON) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,266,227 shares.
The largest 10 holders included
Omega Fund Management, LLC, BVF INC/IL, Vida Ventures Advisors, LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, PARTNERS CAPITAL INVESTMENT GROUP, LLP, Artal Group S.A., Nextech Invest Ltd., Alphabet Inc., and BlackRock Inc..
This page lists
63
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.